References
- McNamara RL, Tamariz LJ, Segal JB, et al. Management of atrial fibrillation: review of the evidence for the role of pharmacologic therapy, electrical cardioversion, and echocardiography. Ann Intern Med 2003; 139(12): 1018–33
- Naccarelli GV, Wolbrette DL, Bhatta L, et al. A review of clinical trials assessing the efficacy and safety of newer antiarrhythmic drugs in atrial fibrillation. J Interv Card Electrophysiol 2003; 9(2): 215–22
- Oral H, Scharf C, Chugh A, et al. Catheter ablation for paroxysmal atrial fibrillation: segmental pulmonary vein ostial ablation versus left atrial ablation. Circulation 2003; 108(19): 2355–60
- Falk RH. Atrial fibrillation. N Engl J Med 2001; 344(14): 1067–78 [Erratum, N Engl J Med 2001; 344(24): 1876]
- Anderson JL, Allen Maycock CA, Lappe DL, et al; Intermountain Heart Collaborative Study Group. Frequency of elevation of C-reactive protein in atrial fibrillation. Am J Cardiol 2004; 94(10): 1255–9
- Marcucci R, Betti I, Cecchi E, et al. Hyperhomocysteinemia and vitamin B6 deficiency: New risk markers for nonvalvular atrial fibrillation? Am Heart J 2004; 148(3): 456–61
- Snow V, Weiss KB, LeFevre M, et al; AAFP Panel on Atrial Fibrillation; ACP Panel on Atrial Fibrillation. Management of newly detected atrial fibrillation: a clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians. Ann Intern Med 2003; 139(12): 1009–17
- Asher CR, Klein AL; ACUTE trial. Transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation: ACUTE trial update. Card Electrophysiol Rev 2003; 7(4): 387–91
- Wyse DG, Waldo AL, DiMarco JP, et al; Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002; 347(23): 1825–33
- Van Gelder IC, Hagens VE, Bosker HA, et al; Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002; 347(23): 1834–40
- Khan I A, Nair CK, Singh N, et al. Acute ventricular rate control in atrial fibrillation and atrial flutter. Int] Cardiol 2004; 97(1): 7–13
- Miller MR, McNamara RL, Segal JB, et al. Efficacy of agents for pharmacologic conversion of atrial fibrillation and subsequent maintenance of sinus rhythm: a meta-analysis of clinical trials. J Fam Pract 2000; 49(11): 1033–46
- Naccarelli GV, Wolbrette DL, Khan M, et al. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials. Am J Cardiol 2003; 91(6A): 15–26D
- Roy D, Talajic M, Dorian P, et al. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med 2000; 342(13): 913–20
- Aliot E, De Chillou C, Sadoul N. Catheter ablation or modulation of the AV node. Card Electrophysiol Rev 2002; 6(4): 406–13
- de Lima GG, Kalil RA, Leiria TL, et al. Randomized study of surgery for patients with permanent atrial fibrillation as a result of mitral valve disease. Ann Thorac Surg 2004; 77(6): 2089–94; discussion 2094–5
- Haissaguerre M, Jais P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998; 339(10): 659–66
- Mansour M, Ruskin J, Keane D. Efficacy and safety of segmental ostial versus circumferential extra-ostial pulmonary vein isolation for atrial fibrillation. J Cardiovasc Electrophysiol 2004; 15(5): 532–7